Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Jan 10, 2021 12:49pm
149 Views
Post# 32263361

RE:RE:Phase 2 study Inquiry

RE:RE:Phase 2 study Inquiry
StevenBirch wrote: I think they have learned a lot since the first lockdown last spring and maybe most importantly is that there are other illnesses and medical emergencies that are a priority also. I would be very disappointed if they had to delay again for various reasons and I think that is just speculation at this point. 

Case in point, they are testing a treatment/vaccine for covid and we don't hear anything? So I wouldn't take silence as a delay rather just a lack of urgency by the company to keep us informed.


VentureGuy24 wrote: Are we enrolling and treating patients? Has covid wave 2 caused another delay? This company has been very silent on all fronts. I fear our trial just got extended again.




I'm expecting some great news out of TLT soon, maybe this month still. Something from Dr. Coombs. Some CR data from Phase 2. If they are both good then we may see that .50c number fall pretty damn quick.

<< Previous
Bullboard Posts
Next >>